Affinity Asset Advisors, LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
+245,132
(11.1%)
New positions
25
Sold out positions
19
Turnover %
23.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| FIRST TRACKS BIOTHERAPEUTICS | 32,831 | 80.3% |
| VOGENX INC | 20,853 | NEW |
| ARVN | 15,857 | NEW |
| BLTE | 15,703 | 61.8% |
| ARWR | 15,589 | 127.5% |
| ODYSSEY THERAPEUTICS INC | 13,659 | 95.3% |
| TYRA | 12,202 | 191.0% |
| CLDX | 11,565 | 44.4% |
| IBRX | 11,139 | NEW |
| BEAM | 11,003 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
694,737
(28.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|